Logo1
PSHP - 2016 PSHP Annual Assembly
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
PHARMACISTS ONLY -- Please provide the following:
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
Objective 1: Provide pharmacists and technicians with updates in disease state and drug therapy management
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Objective 2: Provide pharmacists and technicians with updates to general pharmacy practice
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Provide pharmacists and technicians with updates in the area of patient safety
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Describe the current state and future direction of PSHP
Identify key metrics for PSHP
Review key updates from ASHP House of Delegates and other initiatives
Discuss current trends in pharmacy practice
Identify membership trends for PSHP
Describe opportunities for Pharmacy Technicians related to the Practice Advancement Initiative
Review the updated policies from the ASHP House of Delegates related to Pharmacy Technicians
Discuss changes to Pharmacy Technician training and education
Identify the 2016-2017 ISMP standards
Understand the literature behind all of the 2016-2017 ISMP standards
Evaluate the current recommendations prepared by ISMP for deficiencies in their practice sites
Find new ISMP standards to execution into their practice site
Identify the 2016-2017 ISMP standards associated with high alert medications
Understand the reasoning behind the new 2016-2017 ISMP standards
Examine the current recommendations as options to consider for implementation into their hospital/practice sites
Recognize opportunities for technicians to become involved in implementation for new ISMP standards reviewed
Identify if a medication is safe to take for a patient who is pregnant or breastfeeding
Describe the current risk classifications for medications in pregnancy and breastfeeding
List resources for information regarding use of medications in pregnancy and breast feeding
Recognize changes regarding medication labeling in special populations, including pregnant patients, lactating patients and patients with reproductive potential
Identify resources that can be utilized in determining if medications are safe in pregnancy and lactation
Review the safety categories listings for medications in pregnancy and lactation
List the different stages of pregnancy and how they will be affected by medications
Describe the law as it relates to direct supervision of pharmacy technicians
Discuss the process and benefits of telepharmacy from a patient’s perspective
Discuss the legal requirements for remote technician management through the use of telepharmacy systems
Discuss the opportunities for improving clinical care team management through the use of telepharmacy
Describe the role of the technician in a telepharmacy operation
Discuss the process and benefits of telepharmacy from a technician perspective
Describe the safety steps implemented in the telepharmacy system
Discuss the legal requirements for a telepharmacy system
Describe the pharmacy profession’s efforts in pursuing provider status at the national level
Describe the areas of focus for ASHP related to opioid overuse
List two organizations ASHP is working with to promote pharmacist’s concerns and role in opioid overuse
Describe market place information on the pharmacy workforce, growth in residency training programs and BPS credentialing and identify the future impact on health system practice
Explain how provider status impacts pharmacy technicians’ role in the profession
Explain the trend of opioid use in the United States over the last decade
State one group who ASHP is collaborating with regarding opioid overuse
State what year candidates applying for initial PTCB certification must complete an ASHP-accredited education program
Identify the latest areas of FDA enforcement
Identify the constitution of your core FDA Inspection Team
Create the outline of an appropriate FDA response
Identify the latest areas of FDA enforcement
Determine the difference between guidances and regulations
Incorporate the importance of an inspection in an appropriate technician response
Identify the three categories of hazardous drugs
State the garbing requirements when compounding hazardous drugs
Identify the cleaning process steps when handling hazardous drugs
List common examples of types of hazardous drugs
State the reason to complete an Assessment of Risk
List the specific type of gloves to wear when handling hazardous drugs
List the type of solutions to use when cleaning hazardous drug areas
Distinguish when dosing adjustments are necessary based on renal function
Describe why one would misuse or abuse opioids for non-medical purposes
Explain the necessary steps to prepare for your medical missions trip
Choose the proper reversal medication depending on the anticoagulant a patient presents on
Define misuse, abuse, and diversion
State the different steps in preparing to go on a medical mission trip
Compare FDA-approved treatment options for genotype 1 HCV infections
Distinguish the various levels of error reduction strategies in medication safety
Explain the role of the immune system in cancer therapy
Identify agents used in the treatment of HCV infections
Choose appropriate medication safety resources for pediatrics
Define the parts of the immune system related to cancer therapy
Describe how professionalism is cultivated throughout both the didactic and experiential components of the pharmacy curriculum
Discuss the powerful influence preceptors exert in instilling professionalism in pharmacy students
Outline practical examples for guiding students in conducting themselves professionally in our highly technical world
Describe why professionalism is an important component of pharmacy education
Discuss the role pharmacy technicians play in modeling appropriate professional behavior in the pharmacy setting
Recommend practical examples for supporting students through the use of technology
Recite 3 free technologies available for preceptors to place useful information for students to access
Reflect upon the utility of using games to improve information retention
State the utility of using polling systems to improve information retention
List 3 logistical issues that pharmacy students struggle with while on clinical rotations
Name the games that may be used in pharmacy student education
Describe how polling systems can be used in pharmacy student education
Utilize the ACIP 2016 immunization schedules to design patient-specific immunization schedules to assist in decreasing the incidence of vaccine-preventable diseases
Describe the various 2016-2017 influenza virus and pneumococcal vaccines and determine specific indications, contra-indications and proper administration
Discuss the various meningococcal vaccines and their indications and schedules
Review the efficacy of pertussis and other vaccines in decreasing hospital admissions
Learn how to properly use the ACIP immunization schedule to assist in decreasing the incidence of vaccine-preventable diseases
Describe the various 2016-2017 influenza virus and pneumococcal vaccines and understand their role in patient therapy
Understand the importance of meningococcal vaccine and their indications
Recognize newly released vaccines and their role in therapy
Discuss demographics of PAI practice in Pennsylvania
Discuss practices supporting PAI initiatives In PA
Discuss ASHP initiatives to engage in this topic
Discuss importance of this technician involvement for all pharmacy roles
Discuss technician practices supporting PAI initiatives
Discuss ASHP initiatives to engage in this topic
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question
Provided by amedco